US EditionAlvotech Announces the Outcome of the Offering in Connection with the Company’s Listing on …
Summary by Stockxpo - A Professional Network of Traders, Investors and Analysts
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Alvotech Announces the Outcome of the Offering in Connection with the Company’s Listing on …
Alvotech (NASDAQ: ALVO) successfully completes its Swedish Depository Receipts (SDRs) offering for Nasdaq Stockholm listing. The offering was multiple times oversubscribed and attracted over 3,000 new shareholders. Trading on Nasdaq Stockholm will commence on May 19, 2025, under the ticker “ALVO SDB”. Alvotech (ALVO, Financial), a biotech company focused on biosimilar medicines, announced the successful completion of its offering of Swedish Depo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
